SCHEMBL5028664

SCHEMBL5028664

CC1=C(c2ccc(F)cc2F)C(=O)NC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
THRB P10828 1/20 0.41
HPGD P15428 1/20 0.41
STK10 O94804 2/20 0.40
SLK Q9H2G2 2/20 0.40
PRKD3 O94806 1/20 0.40
EGFR P00533 1/20 0.40
PRKCG P05129 1/20 0.40
PRKCB P05771 1/20 0.40
MAPT P10636 1/20 0.40
SRC P12931 1/20 0.40
PRKCA P17252 1/20 0.40
PRKCH P24723 1/20 0.40
PRKCI P41743 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKCQ Q04759 1/20 0.40
PRKCZ Q05513 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20595514 0.87 TDP2 (0.49) TDP2MEN1KMT2AALDH1A1THRB
SCHEMBL29944694 0.87 TDP2 (0.49) TDP2MEN1KMT2AALDH1A1THRB
SCHEMBL12424871 0.77 TDP2 (0.46) TDP2MEN1KMT2AALDH1A1THRB
SCHEMBL3671502 0.71 GAA (0.47) MEN1KMT2AALDH1A1EGFRMAPT
SCHEMBL19583334 0.71 GSK3B (0.54) STK10SLKPRKD3PRKCGPRKCB
SCHEMBL21389168 0.69 HRH3 (0.42) TDP2MEN1KMT2AALDH1A1THRB
SCHEMBL1953630 0.69 GRM5 (0.63) TDP2MEN1KMT2APRKD3EGFR
SCHEMBL29535893 0.69 GRM5 (0.63) TDP2MEN1KMT2APRKD3EGFR
SCHEMBL996564 0.67 PTGS2 (0.33) EGFR
SCHEMBL9135463 0.67 ALDH1A1 (0.52) MEN1KMT2AALDH1A1HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1915146-A2 NOVEL 1-ARYL-3-AZABICYCLOÝ3.1.0¨HEXANES: PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS DOV Pharmaceutical, Inc. (US) 2008-04-30 EP disclosed
WO-2007016155-A2 NOVEL 1-ARYL-3-AZABICYCLO[3.1.0]HEXANES: PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS DOV PHARMACEUTICAL, INC. (US) 2007-02-08 WO disclosed